154 related articles for article (PubMed ID: 16054613)
1. Expansion of CD22lo B cells in the spleen of autoimmune-prone flaky skin mice.
Mattsson N; Duzevik EG; Pelsue SC
Cell Immunol; 2005 Apr; 234(2):124-32. PubMed ID: 16054613
[TBL] [Abstract][Full Text] [Related]
2. CD22 regulates thymus-independent responses and the lifespan of B cells.
Otipoby KL; Andersson KB; Draves KE; Klaus SJ; Farr AG; Kerner JD; Perlmutter RM; Law CL; Clark EA
Nature; 1996 Dec 19-26; 384(6610):634-7. PubMed ID: 8967951
[TBL] [Abstract][Full Text] [Related]
3. Differential control of CD22 ligand expression on B and T lymphocytes, and enhanced expression in murine systemic lupus.
Lajaunias F; Ida A; Kikuchi S; Fossati-Jimack L; Martinez-Soria E; Moll T; Law CL; Izui S
Arthritis Rheum; 2003 Jun; 48(6):1612-21. PubMed ID: 12794829
[TBL] [Abstract][Full Text] [Related]
4. Age-related loss of bone marrow pre-B- and immature B-lymphocytes in the autoimmune-prone flaky skin mutant mice.
Welner R; Swett DJ; Pelsue SC
Autoimmunity; 2005 Sep; 38(6):399-408. PubMed ID: 16278144
[TBL] [Abstract][Full Text] [Related]
5. Phosphotyrosine-dependent association between CD22 and protein tyrosine phosphatase 1C.
Campbell MA; Klinman NR
Eur J Immunol; 1995 Jun; 25(6):1573-9. PubMed ID: 7542197
[TBL] [Abstract][Full Text] [Related]
6. Differential expression of the B cell-restricted molecule CD22 on neonatal B lymphocytes depending upon antigen stimulation.
Viemann D; Schlenke P; Hammers HJ; Kirchner H; Kruse A
Eur J Immunol; 2000 Feb; 30(2):550-9. PubMed ID: 10671211
[TBL] [Abstract][Full Text] [Related]
7. Molecular interactions regulate BCR signal inhibition by CD22 and CD72.
Nitschke L; Tsubata T
Trends Immunol; 2004 Oct; 25(10):543-50. PubMed ID: 15364057
[TBL] [Abstract][Full Text] [Related]
8. CD22 regulates early B cell development in BOB.1/OBF.1-deficient mice.
Samardzic T; Gerlach J; Muller K; Marinkovic D; Hess J; Nitschke L; Wirth T
Eur J Immunol; 2002 Sep; 32(9):2481-9. PubMed ID: 12207332
[TBL] [Abstract][Full Text] [Related]
9. The same epitope on CD22 of B lymphocytes mediates the adhesion of erythrocytes, T and B lymphocytes, neutrophils, and monocytes.
Engel P; Nojima Y; Rothstein D; Zhou LJ; Wilson GL; Kehrl JH; Tedder TF
J Immunol; 1993 Jun; 150(11):4719-32. PubMed ID: 7684411
[TBL] [Abstract][Full Text] [Related]
10. B cell defects in SLP65/BLNK-deficient mice can be partially corrected by the absence of CD22, an inhibitory coreceptor for BCR signaling.
Gerlach J; Ghosh S; Jumaa H; Reth M; Wienands J; Chan AC; Nitschke L
Eur J Immunol; 2003 Dec; 33(12):3418-26. PubMed ID: 14635051
[TBL] [Abstract][Full Text] [Related]
11. B cell antigen receptor-evoked calcium influx is enhanced in CD22-deficient B cell lines.
Nadler MJ; McLean PA; Neel BG; Wortis HH
J Immunol; 1997 Nov; 159(9):4233-43. PubMed ID: 9379018
[TBL] [Abstract][Full Text] [Related]
12. CD22 regulates B lymphocyte function in vivo through both ligand-dependent and ligand-independent mechanisms.
Poe JC; Fujimoto Y; Hasegawa M; Haas KM; Miller AS; Sanford IG; Bock CB; Fujimoto M; Tedder TF
Nat Immunol; 2004 Oct; 5(10):1078-87. PubMed ID: 15378059
[TBL] [Abstract][Full Text] [Related]
13. B lymphocytes are required for development and treatment of autoimmune diseases.
Youinou P; Jamin C; Pers JO; Berthou C; Saraux A; Renaudineau Y
Ann N Y Acad Sci; 2005 Jun; 1050():19-33. PubMed ID: 16014517
[TBL] [Abstract][Full Text] [Related]
14. Ig domains 1 and 2 of murine CD22 constitute the ligand-binding domain and bind multiple sialylated ligands expressed on B and T cells.
Law CL; Aruffo A; Chandran KA; Doty RT; Clark EA
J Immunol; 1995 Oct; 155(7):3368-76. PubMed ID: 7561031
[TBL] [Abstract][Full Text] [Related]
15. Regulation of lymphocyte activation by the cell-surface molecule CD22.
Law CL; Sidorenko SP; Clark EA
Immunol Today; 1994 Sep; 15(9):442-9. PubMed ID: 7945784
[TBL] [Abstract][Full Text] [Related]
16. Down-modulation of B cell signal transduction by ligation of mucins to CD22.
Toda M; Akita K; Inoue M; Taketani S; Nakada H
Biochem Biophys Res Commun; 2008 Jul; 372(1):45-50. PubMed ID: 18474217
[TBL] [Abstract][Full Text] [Related]
17. Increased expression of the B-cell-regulatory molecule CD72 in primary Sjögren's syndrome.
Smith AJ; Gordon TP; Macardle PJ
Tissue Antigens; 2004 Mar; 63(3):255-9. PubMed ID: 14989715
[TBL] [Abstract][Full Text] [Related]
18. CD22 x Siglec-G double-deficient mice have massively increased B1 cell numbers and develop systemic autoimmunity.
Jellusova J; Wellmann U; Amann K; Winkler TH; Nitschke L
J Immunol; 2010 Apr; 184(7):3618-27. PubMed ID: 20200274
[TBL] [Abstract][Full Text] [Related]
19. A bispecific recombinant immunotoxin, DT2219, targeting human CD19 and CD22 receptors in a mouse xenograft model of B-cell leukemia/lymphoma.
Vallera DA; Todhunter DA; Kuroki DW; Shu Y; Sicheneder A; Chen H
Clin Cancer Res; 2005 May; 11(10):3879-88. PubMed ID: 15897589
[TBL] [Abstract][Full Text] [Related]
20. CD22 negatively and positively regulates signal transduction through the B lymphocyte antigen receptor.
Sato S; Tuscano JM; Inaoki M; Tedder TF
Semin Immunol; 1998 Aug; 10(4):287-97. PubMed ID: 9695185
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
